Skip to search formSkip to main contentSkip to account menu

MPT Regimen

Known as: Melphalan-Prednisone-Thalidomide Regimen 
A regimen consisting of melphalan, prednisone and thalidomide used as induction therapy for multiple myeloma.
National Institutes of Health

Related topics

Related topics

4 relations
MelphalanMultiple MyelomaPrednisoneThalidomide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Effects of Huachansu Injection Combined MPT Regimen on Multiple Myeloma
Objective To observe the short-term effects of Huachansu injection combined Melphalan,Prednisone,and Thalidomide(MPT) regimen in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)